Colposcopic evaluation in cases of persistent inflammatory Pap smear

Authors

  • Paridhi Choudhary Department of Obstetrics and Gynecology, Subharti Hospital, Meerut, Uttar Pradesh, India
  • Mamta Tyagi Department of Obstetrics and Gynecology, Subharti Hospital, Meerut, Uttar Pradesh, India
  • Smriti Gupta Department of Obstetrics and Gynecology, Subharti Hospital, Meerut, Uttar Pradesh, India
  • Manvi Gupta Department of Obstetrics and Gynecology, Subharti Hospital, Meerut, Uttar Pradesh, India
  • Anita Pandey Department of Microbiology, Subharti Hospital, Meerut, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20220734

Keywords:

PAP smear, Colposcopy, Premalignant lesion, Cervix

Abstract

Background: The aim of the study was to assess the colposcopic evaluation in cases of persistant inflammatory Papanicolaou (Pap) smear.

Methods: This was a prospective analytical study, conducted amongst 78 women attending the outpatient department of obstetrics and gynaecology at Subharti Medical College. Pap smear was performed by the conventional method and colposcopy was done for all 78 sexually active women who came with complaints of pain abdomen, irregular cycles, white discharge per vaginum and urinary tract infections. Final correlation of Pap smear and colposcopy were based on histopathology and human papillomavirus deoxyribonucleic acid (HPV DNA).

Results: In this study of 78 women, 21% of women had normal colposcopic findings whereas 79% had abnormal colposcopic findings. Histopathological examination (HPE) findings revealed that 69% women had cervical intraepithelial neoplasia (CIN) 1, 23% had CIN II, 6% had CIN III and 3% had SCC. 25% women tested positive for HPV DNA and 75% women tested negative for HPV DNA.

Conclusions: Patients with persistent inflammatory Pap smear despite undergoing treatment show changes on Colposcopic directed biopsies.

 

References

Kalyankar VY, Kalyankar BV, Gadappa SN, Kute S. Colposcopic evaluation of unhealthy cervix and it’s correlation with Papanicolau smear in cervical cancer screening. Int J Reprod Contracept Obstet Gynecol. 2017;6:4959-65.

Thobbi VA, Khan F. Cervical cytology by Pap smear in reproductive population. Int J Reprod Contracept Obstet Gynecol. 2018;7:1988-92.

Vincent M. Pap smear as a screening tool for evaluating cervical dysplasia and malignancy a hospital-based study. J Evolution Med Dent Sci. 2019;8(17):1368-71.

Sharma JC, Leekha K. Awareness, positivity of Pap smear in adult females. Indian J Gynecol Oncol. 2018;16(3):46.

Garg R, Desai R. Cytologic and colposcopic evaluation of all symptomatic women at tertiary care centre. Int J Adv Med. 2017;4:799-80.

Manjula A, Indira N, Chaitra R, Priyanca D, Girish BC. Cytological and colposcopic evaluation of unhealthy cervix. J Evid Based Med Healthc. 2015;2(41):6920-7.

Joshi P. Screening of cervical neoplasia in HIV-infected women in India. AIDS. 2013;27(4):607-15.

Downloads

Published

2022-03-25

Issue

Section

Original Research Articles